Garner HE, Hahn AW, Salem C, et al. Cardiac output, left ventricular ejection rate, plasma volume, and heart rate changes in equine laminitis-hypertension. Am J Vet Res 1977;38:725–729.
Eades SC, Holm AS, Moore RM. Effects of an endothelin receptor antagonist and nitroglycerine on digital microvascular function in horses during the prodromal stages of carbohydrate overload laminitis. Am J Vet Res 2006;67:1204–1211.
Allen D Jr, Clark ES, Moore JN, et al. Evaluation of equine digital Starling forces and hemodynamics during early laminitis. Am J Vet Res 1990;51:1930–1934.
Hood DM, Wagner IP, Brumbaugh GW. Evaluation of hoof wall surface temperature as an index of digital vascular perfusion during the prodromal and acute phases of carbohydrate-induced laminitis in horses. Am J Vet Res 2001;62:1167–1172.
Eaton SA, Allen D, Eades SC, et al. Digital Starling forces and hemodynamics during early laminitis induced by an aqueous extract of black walnut (Juglans nigra) in horses. Am J Vet Res 1995;56:1338–1344.
Pollitt CC, Davies CT. Equine laminitis: its development coincides with increased sublamellar blood flow. Equine Vet J Suppl 1998;(26):125–132.
Robinson NE, Scott JB, Dabney JM, et al. Digital vascular responses and permeability in equine alimentary laminitis. Am J Vet Res 1976;37:1171–1176.
Kirker-Head CA, Stephens KA, Toal RL, et al. Circulatory and blood gas changes accompanying the development and treatment of induced laminitis. Equine Vet Sci 1986;6:293–301.
Trout DR, Hornof WJ, Linford RL, et al. Scintigraphic evaluation of digital circulation during the developmental and acute phases of equine laminitis. Equine Vet J 1990;22:416–421.
Adair HS III, Goble DO, Schmidhammer JL, et al. Laminar microvascular flow, measured by means of laser Doppler flowmetry, during the prodromal stages of black walnut-induced laminitis in horses. Am J Vet Res 2000;61:862–868.
Katwa LC, Johnson PJ, Ganjam VK, et al. Expression of endothelin in equine laminitis. Equine Vet J 1999;31:243–247.
Schneider DA, Parks AH, Eades SC, et al. Palmar digital vessel relaxation in healthy horses and in horses given carbohydrate. Am J Vet Res 1999;60:233–239.
Weiss DJ, Geor RJ, Johnston G, et al. Microvascular thrombosis associated with onset of acute laminitis in ponies. Am J Vet Res 1994;55:606–612.
Weiss DJ, Evanson OA, McClenahan D, et al. Effect of a competitive inhibitor of platelet aggregation on experimentally induced laminitis in ponies. Am J Vet Res 1998;59:814–817.
Snyder F. Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators. Am J Physiol 1990;259:C697–V708.
Anfossi G, Cavalot F, Massucco P, et al. Insulin influences immunoreactive endothelin release by human vascular smooth muscle cells. Metabolism 1993;42:1081–1083.
Ferri C, Pittoni V, Piccoli A, et al. Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo. J Clin Endocrinol Metab 1995;80:829–835.
Piatti P, Monti LD, Conti M, et al. Hypertriglyceridemia and hyperinsulinemia are potent inducers of endothelin-1 release in humans. Diabetes 1996;45:316–321.
Wolpert H, Steen SN, Istfan NW, et al. Insulin modulates circulating endothelin-1 levels in humans. Metabolism 1993;42:1027–1030.
Juan C, Shen Y, Chien Y, et al. Insulin infusion induces endothelin-1-dependent hypertension in rats. Am J Physiol 2004;287: E948–E954.
Schott H. Equine Cushing's syndrome associated with pars intermedia dysfunction. Vet Clin North Am Equine Pract 2002;18:237–270.
Field JR, Jeffcott LB. Equine laminitis—another hypothesis for pathogenesis. Med Hypotheses 1989;30:203–210.
Consentino F, Luscher TF. Endothelial dysfunction in diabetes mellitus. J Cardiovasc Pharmacol 1998;32 (suppl 3):S54–S61.
Luscher TF, Dohi Y, Tanner FC, et al. Endothelium-dependent control of vascular tone: effects of age, hypertension and lipids. Basic Res Cardiol 1991;86 (suppl 2):143–158.
Scheikofer S, Balletshofer B, Andrassy M. Endothelial dysfunction in diabetes mellitus. Semin Thromb Hemost 2000;26:503–511.
Pass MA, Pollitt S, Pollitt CC. Decreased glucose metabolism causes separation of hoof lamellae in vitro: a trigger for laminitis?. Equine Vet J Suppl 1998;(26):133–138.
Mobasheri A, Critchlow K, Clegg PD, et al. Chronic equine laminitis is characterized by loss of GLUT-1, GLUT-4, and ENaC positive laminar keratinocytes. Equine Vet J 2004;36:248–254.
Ingle-Fehr JE, Baxter GM. Evaluation of digital and laminar blood flow in horses given a low dose of endotoxin. Am J Vet Res 1998;59:192–196.
Garner HE, Coffman JR, Hahn AW, et al. Equine laminitis of alimentary origin: an experimental model. Am J Vet Res 1975;36:441–444.
Tetens J, Moore RM, Hosgood GL, et al. Effects of infusion of adenosine triphosphate-magnesium chloride on cardiopulmonary and clinicopathologic variables, cytokine activity and endothelin concentrations in horses administered a low dose of endotoxin. Am J Vet Res 2004;65:225–237.
Freestone JF, Wolfsheimer KJ, Kamerling SG, et al. Exercise induced hormonal and metabolic changes in Thoroughbred horses: effects of conditioning and acepromazine. Equine Vet J 1991;23:219–223.
Kronfeld DS, Treiber KH, Geor RJ. Comparison of nonspecific indications and quantitative methods for the assessment of insulin resistance in horses and ponies. J Am Vet Med Assoc 2005;226:712–719.
Korthuis RJ, Granger DN, Taylor AE. A new method for estimating skeletal muscle capillary pressure. Am J Physiol 1984;246: H880–H885.
Ramaswamy CM, Eades SC, Venugopal CS, et al. Plasma concentrations of endothelin-like immunoreactivity in healthy horses and horses with naturally acquired gastrointestinal tract disorders. Am J Vet Res 2002;63:454–458.
Wagner OF, Christ G, Wojta J, et al. Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 1992;267:16066–16068.
Ekelund U, Adner M, Edvinsson L, et al. Effects of the combined ETA and ETB receptor antagonist PD145065 on arteries, arterioles, and veins in the cat hindlimb. J Cardiovasc Pharmacol 1995;26:S211–S213.
Tanus-Santos JE, Gordo WM, Udelsmann A, et al. Nonselective endothelin-receptor antagonism attenuates hemodynamic changes after massive pulmonary air embolism in dogs. Chest 2000;118:175–179.
Robinson NE. Digital blood flow, arteriovenous anastomoses and laminitis. Equine Vet J 1990;22:381–383.
Weiss DJ. Equine laminitis: a review of recent research. Equine Pract 1997;19:16–20.
Hood DM, Amoss MS, Hightower D. Equine laminitis I: radio-isotopic analysis of the hemodynamics of the foot during the acute disease. J Equine Med Surg 1978;2:439–444.
Schmidt O, Deegen E, Fuhrmann H, et al. Effects of fat feeding and energy level on plasma metabolites and hormones in Shetland ponies. J Vet Med A Phsyiol Pathol Clin Med 2001;48:39–49.
Moore JN, Garner HE, Coffman JR. Haematological changes during development of acute laminitis hypertension. Equine Vet J 1981;13:240–242.
Johnson PJ, Messer NT, Ganjam VK. Cushing's syndromes, insulin resistance, and endocrinopathic laminitis. Equine Vet J 2004;36:194–198.
Keen JA, McLaren M, Chandler KJ, et al. Biochemical indices of vascular function, glucose metabolism, and oxidative stress in horses with equine Cushing's disease. Equine Vet J 2004;36:226–229.
Said SA, Ammar el SM, Suddek GM. Effects of bosentan (ETA/ ETB receptor antagonist) on metabolic changes during stress and diabetes. Pharmacol Res 2005;51:107–115.
Weiss DJ, Evanson OA, McClenahan D, et al. Evaluation of platelet activation and platelet-neutrophil aggregates in ponies with alimentary laminitis. Am J Vet Res 1997;58:1376–1380.
Uhlmann D, Glasser S, Gaebel G, et al. Improvement of post-ischemic hepatic microcirculation after endothelin A receptor blockade-endothelin antagonism influences platelet-endothelium interactions. J Gastrointest Surg 2005;9:187–197.
Uhlmann D, Glasser S, Lauer H, et al. Endothelin-a receptor blockade improves postischemic hepatic microhemodynamics. J Cardiovasc Pharmacol 2004;44 (suppl I):S103–S104.
Advertisement
Objective—To quantify changes in endothelium-derived factors and relate those changes to various aspects of digital hemodynamics during the prodromal stages of carbohydrate overload (CHO)-induced laminitis in horses.
Animals—20 adult horses without abnormalities of the digit.
Procedures—Digital and jugular venous blood samples were collected at 1-hour intervals (for assessment of endothelin-1 [ET-1] immunoreactivity and measurement of glucose, insulin, and nitric oxide [NO] concentrations) or 4-hour intervals (CBC and platelet-neutrophil aggregate assessment) for 8 hours or 16 hours after induction of CHO-associated laminitis in horses treated with an ET-1 antagonist. Effects of treatment, collection site, and time and the random effects of horse on each variable were analyzed by use of a repeated-measures model. Where treatment and collection site had no significant effect, data were combined.
Results—Compared with baseline values, CHO resulted in changes in several variables, including a significant increase from baseline in digital blood ET-like immunoreactivity at 11 hours; digital blood ET-like immunoreactivity was significantly greater than that in jugular venous blood at 8, 9, 11, and 12 hours. Digital and jugular venous blood concentrations of glucose increased from baseline significantly at 3, 4, and 5 hours; insulin concentration increased significantly at 5 hours; and the number of platelet-neutrophil aggregates increased significantly at 12 hours.
Conclusions and Clinical Relevance—In horses, concurrent increases in venous blood ET-1 immunoreactivity, insulin and glucose concentrations, and platelet-neutrophil aggregates support a role of endothelial dysfunction in the pathogenesis of CHO-induced laminitis.
Dr. LeBlanc's present address is Department of Pathobiology, College of Veterinary Medicine, University of Tennessee, Knoxville, TN 37996.
Supported by a grant from the USDA National Research Initiative.
The authors thank Michael Keowen, Catherine Koch, and Frank Garza for technical assistance.